Document Detail

Bioactive food components and cancer-specific metabonomic profiles.
MedLine Citation:
PMID:  21113295     Owner:  NLM     Status:  MEDLINE    
Cancer cells possess unique metabolic signatures compared to normal cells, including shifts in aerobic glycolysis, glutaminolysis, and de novo biosynthesis of macromolecules. Targeting these changes with agents (drugs and dietary components) has been employed as strategies to reduce the complications associated with tumorigenesis. This paper highlights the ability of several food components to suppress tumor-specific metabolic pathways, including increased expression of glucose transporters, oncogenic tyrosine kinase, tumor-specific M2-type pyruvate kinase, and fatty acid synthase, and the detection of such effects using various metabonomic technologies, including liquid chromatography/mass spectrometry (LC/MS) and stable isotope-labeled MS. Stable isotope-mediated tracing technologies offer exciting opportunities for defining specific target(s) for food components. Exposures, especially during the early transition phase from normal to cancer, are critical for the translation of knowledge about food components into effective prevention strategies. Although appropriate dietary exposures needed to alter cellular metabolism remain inconsistent and/or ill-defined, validated metabonomic biomarkers for dietary components hold promise for establishing effective strategies for cancer prevention.
Young S Kim; John A Milner
Related Documents :
22129345 - Glass transition temperature and its relevance in food processing.
24270255 - Spraying food sources with pyrethroid to control peridomestic triatomines.
23204155 - Dairy consumption and diet quality in a sample of australian children.
22849285 - Impact assessment of risk management interventions.
11516115 - Variable-ratio versus variable-interval schedules: response rate, resistance to change,...
8703245 - Monoclonal antibody-based dot-blot elisa for the detection of salmonella in foods.
Publication Detail:
Type:  Journal Article; Review     Date:  2010-11-11
Journal Detail:
Title:  Journal of biomedicine & biotechnology     Volume:  2011     ISSN:  1110-7251     ISO Abbreviation:  J. Biomed. Biotechnol.     Publication Date:  2011  
Date Detail:
Created Date:  2010-11-29     Completed Date:  2011-03-31     Revised Date:  2013-07-03    
Medline Journal Info:
Nlm Unique ID:  101135740     Medline TA:  J Biomed Biotechnol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  721213     Citation Subset:  IM    
Nutritional Science Research Group, Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Chromatography, Liquid / methods
Fatty Acid Synthetase Complex / metabolism
Glucose / metabolism
Health Promotion / methods
Mass Spectrometry / methods
Metabolomics / methods*
Neoplasms / metabolism*,  prevention & control
Pentose Phosphate Pathway
Protein-Tyrosine Kinases / metabolism
Reg. No./Substance:
50-99-7/Glucose; EC Kinases; EC 6.-/Fatty Acid Synthetase Complex

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Clinical application of human mesenchymal stromal cells for bone tissue engineering.
Next Document:  Superior thyroid cornu anatomical variation causing globus pharyngeous and Dysphagia.